Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II study of ProHema for hematologic malignancies begins

Nov. 28, 2012

Amgen synthesizes novel protein kinase inhibitors

Nov. 28, 2012

Ruga presents next-generation B-raf V600E inhibitors

Nov. 28, 2012

MMRF partners with the Department of Veterans Affairs

Nov. 28, 2012

EMA accepts for review MAAs for vintafolide and etarfolatide

Nov. 28, 2012

CAP-7.1 evaluated in patients with solid tumors

Nov. 28, 2012

New CDK8 inhibitors designed for the treatment of colorectal cancer

Nov. 27, 2012

First-in-human trial of a new class of DNA repair inhibitors

Nov. 27, 2012

Chemokine CXCR7 receptor antagonist CCX-662 tested in glioblastoma model

Nov. 27, 2012

Daiichi Sankyo presents in vitro and in vivo data for DS-7423

Nov. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...